NCT01340937
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +34 more
- Locations
-
Not specified
Clinical trial condition
Tetanus
Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.
272 public trials
11 recruiting studies
Tetanus trial results
NCT00290342
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Bucheon-si, South Korea
- GSK Investigational Site Daegu, South Korea
- GSK Investigational Site Gwangju, South Korea
- GSK Investigational Site Incheon, South Korea
NCT00871117
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Antioch, California, United States
- GSK Investigational Site Daly City, California, United States
- GSK Investigational Site Hayward, California, United States
- GSK Investigational Site Redwood City, California, United States
NCT01147900
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Leuven, Belgium
- GSK Investigational Site Wilrijk, Belgium
NCT01248884
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Santo Domingo, Dominican Republic
- GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
- GSK Investigational Site Espoo, Finland
- GSK Investigational Site Helsinki, Finland
NCT01090453
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Vancouver, British Columbia, Canada
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site Hamilton, Ontario, Canada
- GSK Investigational Site Aix-en-Provence, France
NCT00282295
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
- Locations
-
- GSK Investigational Site Chandler, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Golden, Colorado, United States
Completed
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
NCT01245049
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site St Austell, Cornwall, United Kingdom
- GSK Investigational Site Southampton, Hampshire, United Kingdom
- GSK Investigational Site Axbridge, Somerset, United Kingdom
- GSK Investigational Site Taunton, Somerset, United Kingdom
NCT00317135
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- GSK Investigational Site City of Muntinlupa, Philippines
NCT00317187
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- GSK Investigational Site Bangkok, Thailand